Daejeon, South Korea

Jung Min Yun

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jung Min Yun. Retrieved from https://idiyas.com/inventor/jung-min-yun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jung Min Yun: Innovator in Pharmaceutical Chemistry

Introduction

Jung Min Yun is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Jung Min Yun holds a patent for a compound titled "Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate." This invention relates to a 1.5 hydrate of the compound, a process for preparing it, and a pharmaceutical composition for inhibiting DPP-IV, which includes this compound as the active component. He has 1 patent to his name.

Career Highlights

Jung Min Yun is currently employed at LG Life Sciences, Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company.

Collaborations

He has collaborated with notable coworkers, including Ki Sook Park and Bong Chan Kim, contributing to various projects within the organization.

Conclusion

Jung Min Yun's work in pharmaceutical chemistry exemplifies the impact of innovation in healthcare. His contributions through patents and collaborations highlight the importance of research and development in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…